Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Hum Reprod 2018;33:1602–1618

The journal, Human Reproduction, would like to apologise for an error under the sub-section Biochemical hyperandrogenism of Table III in the above article. The following statement:

Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time.

Should read:

Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for 3 months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time.

The electronic version of this article has been updated at https://doi.org/10.1093/humrep/dey256. The Journal would like to assure readers that this does not affect any other content of the article.